Best of 2023: Cost-Effective Use of Biological and Targeted Synthetic DMARDs An international task force of 13 European experts have developed evidence-based points to consider regarding the cost-effective use of biological and targeted synthetic disease. https://t.co/UAlpww3fmi https://t.co/NpkTgwDuRl